News

A study conducted at the Zuckerman Institute of Columbia University (USA) by Jerome Munuera, co-first author and researcher at the Paris Brain Institute, and his collaborators, led to the development of the first functional model of abstraction in...

On November 18, Station F unveiled the second edition of its Future 40 ranking. 2 startups hosted in our incubator iPEPS -The Healthtech Hub are included: Healthy Mind and Uptale.

The Paris Brain Institute has acquired a new state-of-the-art multi-photon microscope thanks to the support of the Edmond J. Safra Foundation. This custom-built microscope will enable several teams at the Institute to carry out highly advanced...

Paris, October 19th, 2020 - ALS is characterized by the degeneration of motor neurons resulting in a progressive and irreversible deficit in walking and speech, until a complete paralysis of all muscles, including those controlling respiration. The...

A study by researchers and clinicians from the Paris Brain Institute (Inserm/CNRS/Sorbonne University) and AP-HP (Henri Mondor and Pitié-Salpêtrière Hospitals) confirms the beneficial effect of deep brain stimulation on several brain structures in...

Richard Mille, new member of the Paris Brain Institute's Campaign Committee, mobilizes his company and supports actions to finance research programs and increase the Institute's visibility.

Huntington's disease is a genetic neurological disorder that generally appears in adulthood. Teams of researchers and clinicians at the Grenoble Institute of Neuroscience (Inserm/Grenoble Alpes University) and the Brain Institute (Inserm/Sorbonne...

DOES MULTIPLE SCLEROSIS (MS) ALTER THE RISK OF DEVELOPING A SEVERE FORM OF COVID-19 INFECTION? WHAT ARE THE CLINICAL FEATURES AND EFFECTS OF CORONAVIRUS INFECTION IN PATIENTS WITH MS? DO SPECIFIC TREATMENTS FOR SEPSIS INCREASE OR DECREASE THE...

The Paris Brain Institute, in partnership with the AP-HP, Sorbonne-Université, Medico-University Department of Neurosciences at the Pitié-Salpêtrière Hospital, with grant of €400,000 from the FIA Foundation - historical patron of the Institute with a...

The research team led by Prof. Lionel Naccache at the Paris Brain Institute (Sorbonne Université, APHP, INSERM, CNRS) has just published two important studies which concern patients suffering from a lasting disturbance of consciousness (e.g...

MSCopilot, a new multiple sclerosis self-assessment digital solution developed by AdScientiam a startup incubated at iPEPS, has been clinically validated in a clinical trial involving several French hospitals. The results are published in the...

A high tumour mutational burden (hypermutation) is observed in some gliomas 1, 2, 3, 4, 5; however, the mechanisms by which hypermutation develops and whether it predicts the response to immunotherapy are poorly understood.